WELLINGTON MANAGEMENT CO LLP 13D and 13G filings for Reata Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-09-09 10:26 am Sale |
2022-08-31 | 13G | Reata Pharmaceuticals, Inc. RETA |
WELLINGTON MANAGEMENT CO LLP | 1,508,638 4.780% |
-2,744,339 (-64.53%) |
Filing |
| 2022-02-04 09:22 am Sale |
2021-12-31 | 13G | Reata Pharmaceuticals, Inc. RETA |
WELLINGTON MANAGEMENT CO LLP | 4,252,977 13.510% |
-92,747 (-2.13%) |
Filing |
| 2021-02-04 09:57 am Purchase |
2020-12-31 | 13G | Reata Pharmaceuticals, Inc. RETA |
WELLINGTON MANAGEMENT CO LLP | 4,345,724 13.990% |
1,324,800 (+43.85%) |
Filing |